Similar Outcomes of Cryopreserved Allogeneic Peripheral Stem Cell Transplants (PBSCT) Compared to Fresh Allografts

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 10, 2007, Pages 1233-1243

  Kim, Dong Hwan ^a,b   Jamal, Nazir ^a   Saragosa, Ronnie ^a   Loach, David ^a   Wright, Janice ^a   Gupta, Vikas ^a   Kuruvilla, John ^a   Lipton, Jeffrey H ^a   Minden, Mark ^a   Messner, Hans A ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Allogeneic peripheral blood stem cell transplantation; Cryopreservation

Indexed keywords

CYCLOSPORIN A; DIMETHYL SULFOXIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGRAFT; ARTICLE; BRADYCARDIA; BURST FORMING UNIT E; CANADA; CANCER MORTALITY; CANCER RECURRENCE; CD34 SELECTION; CELL POPULATION; CELL SURVIVAL; CELL VIABILITY; CHEST TIGHTNESS; CHILL; CHRONIC GRAFT VERSUS HOST DISEASE; CLONOGENESIS; COLONY FORMING UNIT; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; COLONY FORMING UNIT MEG; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; ENGRAFTMENT; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYELOABLATIVE CONDITIONING; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NEUTROPHIL; OUTCOMES RESEARCH; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; STEM CELL MOBILIZATION; THAWING; THROMBOCYTE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; CRYOPRESERVATION; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548677736     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.07.003     Document Type: Article

References (36)

1. Kessinger A., Schmit-Pokorny K., Smith D., and Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 5 Suppl 1 (1990) 25-27
2. Williams S.F., Bitran J.D., Richards J.M., et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant 5 (1990) 129-133
3. Jacobs P., Wood L., and Horak S. Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation. J Clin Apher 6 (1991) 54-58
4. Harada M., Taniguchi S., Teshima T., et al. Cryopreservation, cytokine mobilization, and autotransplantation of peripheral blood stem cells. Prog Clin Biol Res 377 (1992) 297-308
5. Zambelli A., Poggi G., Prada G.D., et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 18 (1998) 4705-4708
6. Zenhausern R., Tobler A., Leoncini L., Hess O.M., and Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 79 (2000) 523-526
7. Keung Y.K., Lau S., Elkayam U., Chen S.C., and Douer D. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant 14 (1994) 363-367
8. Alessandrino P., Bernasconi P., Caldera D., et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 23 (1999) 533-537
9. de Vries E.G., Vellenga E., Kluin-Nelemans J.C., and Mulder N.H. The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications. Eur J Cancer 40 (2004) 1987-1992
10. Handelsman H. Autologous peripheral stem-cell transplantation. Health Technol Assess (Rockv) (1995) 1-16
11. Shpall E.J., Champlin R., and Glaspy J.A. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant 4 (1998) 84-92
12. Saba N., Abraham R., and Keating A. Overview of autologous stem cell transplantation. Crit Rev Oncol Hematol 36 (2000) 27-48
13. Stockschlader M., Kruger W., Dieck A., et al. Use of cryopreserved bone marrow in unrelated allogeneic transplantation. Bone Marrow Transplant 17 (1996) 197-199
14. Stockschlader M., Hassan H.T., Krog C., et al. Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation. Br J Haematol 96 (1997) 382-386
15. Harris D.T., Schumacher M.J., Rychlik S., et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant 13 (1994) 135-143
16. Frey N.V., Lazarus H.M., and Goldstein S.C. Has allogeneic stem cell cryopreservation been given the "cold shoulder"?. An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation. Bone Marrow Transplant 38 (2006) 399-405
17. Galmes A., Besalduch J., Bargay J., et al. Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at -80 degrees C without rate-controlled freezing. Transfusion 36 (1996) 794-797
18. Galmes A., Besalduch J., Bargay J., et al. A simplified method for cryopreservation of hematopoietic stem cells with -80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant. Leuk Lymphoma 17 (1995) 181-184
19. Galmes A., Besalduch J., Bargay J., et al. Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion 39 (1999) 70-73
20. Itoh T., Minegishi M., Fushimi J., et al. A simple controlled-rate freezing method without a rate-controlled programmed freezer provides optimal conditions for both large-scale and small-scale cryopreservation of umbilical cord blood cells. Transfusion 43 (2003) 1303-1308
21. Pond G.R., Lipton J.H., and Messner H.A. Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population. Biol Blood Marrow Transplant 12 (2006) 422-429
22. Gupta V., Daly A., Lipton J.H., et al. Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. Biol Blood Marrow Transplant 11 (2005) 764-772
23. Kiss T.L., Panzarella T., Messner H.A., et al. Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 31 (2003) 73-78
24. Messner H.A. Long-term outcome of allogeneic transplants in acute myeloid leukemia. Leukemia 16 (2002) 751-752
25. Fietz T., Reufi B., Mucke C., Thiel E., and Knauf W.U. Flow cytometric CD34+ determination in stem cell transplantation: before or after cryopreservation of grafts?. J Hematother Stem Cell Res 11 (2002) 429-435
26. Abrahamsen J.F., Wentzel-Larsen T., and Bruserud O. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2×10(6) CD34+ cells/kg. Cytotherapy 6 (2004) 356-362
27. Korbling M., Huh Y.O., Durett A., et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86 (1995) 2842-2848
28. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
29. Parimon T., Au D.H., Martin P.J., and Chien J.W. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 144 (2006) 407-414
30. Webb I.J., Coral F.S., Andersen J.W., et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 36 (1996) 782-788
31. Schwella N., Zimmermann R., Heuft H.G., et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 67 (1994) 32-35
32. Cashen A.F., Nervi B., and DiPersio J. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol 3 (2007) 19-27
33. Fruehauf S., Seeger T., and Topaly J. Innovative strategies for PBPC mobilization. Cytotherapy 7 (2005) 438-446
34. Eckardt J.R., Roodman G.D., Boldt D.H., et al. Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMT. Bone Marrow Transplant 11 (1993) 125-131
35. Auletta J.J., and Lazarus H.M. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant 35 (2005) 835-857
36. Xu Y., Kashiwakura I., and Takahashi T.A. High sensitivity of megakaryocytic progenitor cells contained in placental/umbilical cord blood to the stresses dugin cryopreservation. Bone Marrow Transplant 34 (2004) 537-543